1. |
Xu M, Real FX, Welt S, et al. Expression of TAG72 in normal colon, transitional mucosa, and colon cancer [J]. Int J Cancer, 1989; 44(6)∶985.
|
2. |
Werther JL, RiveraMacMurray S, Bruckner H, et al. Mucinassociated sialosylTn antigen expression in gastric cancer correlates with an adverse outcome [J]. Br J Cancer,1994; 69(3)∶613.
|
3. |
Kjeldsen T, Clausen H, Hirohashi S, et al. Preparation and characterization of monoclonal antibodies directed to the tumorassociated Olinked sialosyl26 alphaNacetylgalactosaminyl (sialosylTn) epitope [J]. Cancer Res,1988; 48(8)∶2214.
|
4. |
Hombach A, Heuser C, Sircar R, et al. T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibodylike specificity for a carbohydrate epitope [J]. Gastroenterology, 1997; 113(4)∶1163.
|
5. |
AlvarezVallina A, Hawkins RE. Antigenspecific targening of CD28 mediated T cell costimulation using chimeric singlechain antibody variable fragmentCD28 receptors [J]. Eur J Immunol,1996; 26(10)∶2304.
|
6. |
Hombach A, Wieczarkowiecz A, Marquardt T,et al. Tumorspecific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule [J]. J Immunol, 2001; 167(11)∶6123.
|
7. |
Hombach A, Sent D, Schneider C,et al. Tcell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptormediated Tcell proliferation but does not affect receptormediated target cell lysis [J]. Cancer Res,2001; 61(5)∶1976.
|